I INDIVIOR PLC
| Market Cap | $3.81B |
| P/E Ratio | 18.58 |
| Forward P/E | 8.85 |
| Dividend Yield | — |
| Beta | 1.21 |
| 52W Range | $8.81 - $36.60 |
| # Hedge Funds | 1 |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
Hedge Fund Ownership
| Investor 1 | % of Portfolio Weight of this stock in the investor's portfolio | Value Total dollar value of the position | Shares Number of shares held | Activity Portfolio change type: New, Increased, Decreased, or Sold |
|---|---|---|---|---|
| Howard Marks Oaktree Capital Management | 3.63% | $255.06M | 7,108,644 | Reduce 97.24% |
Insider Trading
| Insider Name of the company insider who made the trade 13 | Type Purchase (buy) or Sale (sell) | Shares Number of shares traded | Price Price per share at time of transaction | Value Total dollar value of the transaction | Trade Date Date the transaction was executed | Filing Date Date the SEC filing was submitted |
|---|---|---|---|---|---|---|
| Ryan Barbara | Buy | 8 | $31.09 | $248.68 | 13 Mar 2026 | 13 Mar 2026 |
| Ryan Barbara | Buy | 31 | $32.56 | $1.01K | 09 Mar 2026 | 09 Mar 2026 |
| Kingsley Stuart A | Buy | 940 | $31.87 | $29.95K | 06 Mar 2026 | 06 Mar 2026 |
| Wheadon David E. | Buy | 1,771 | $35.39 | $62.68K | 05 Jan 2026 | 07 Jan 2026 |
| NINIVAGGI DANIEL A | Buy | 775 | $35.39 | $27.43K | 05 Jan 2026 | 07 Jan 2026 |
| Ryan Barbara | Buy | 775 | $35.39 | $27.43K | 05 Jan 2026 | 07 Jan 2026 |
| Humphreys Keith | Buy | 775 | $35.39 | $27.43K | 05 Jan 2026 | 07 Jan 2026 |
| Stejbach Mark | Buy | 775 | $35.39 | $27.43K | 05 Jan 2026 | 07 Jan 2026 |
| David E. WheadonDirector | Buy | 1,771 | $35.39 | $62.68K | 05 Jan 2026 | 07 Jan 2026 |
| Barbara RyanDirector | Buy | 775 | $35.39 | $27.43K | 05 Jan 2026 | 07 Jan 2026 |
| Mark StejbachDirector | Buy | 775 | $35.39 | $27.43K | 05 Jan 2026 | 07 Jan 2026 |
| Daniel A NinivaggiDirector | Buy | 775 | $35.39 | $27.43K | 05 Jan 2026 | 07 Jan 2026 |
| Keith HumphreysDirector | Buy | 775 | $35.39 | $27.43K | 05 Jan 2026 | 07 Jan 2026 |
Frequently Asked Questions
What is INDV stock price today?
INDIVIOR PLC (INDV) is currently trading at $30.47. The stock has a 52-week range of $8.81 to $36.60 and a market capitalization of $3.81B.
Is INDV a good stock to buy in 2026?
INDIVIOR PLC has a P/E ratio of 18.6 (forward P/E: 8.9), a dividend yield of none, and 1-year performance of +224.8%. 1 hedge funds hold this stock. Review the fundamentals and ownership data above to make an informed decision.
Are insiders buying or selling INDV stock?
There have been 13 insider transactions for INDV in recent months. Insider buys can signal management confidence, while sales may reflect diversification or personal financial planning. Check the Insider Trading section above for details.
How has INDV stock performed over the past year?
INDIVIOR PLC (INDV) has returned +224.8% over the past 12 months. The stock traded between $8.81 and $36.60 during this period, and is currently at $30.47.
Which hedge funds own INDV (INDIVIOR PLC)?
1 tracked hedge funds currently hold INDV in their portfolios as of the latest 13F filings. See the ownership table above for the complete list.
What is INDV's market cap and valuation?
INDIVIOR PLC (INDV) has a market capitalization of $3.81B. The trailing P/E ratio is 18.6 and forward P/E is 8.9. The stock is classified in the Healthcare sector.
What is INDV's revenue and profitability?
INDIVIOR PLC reported revenue of $1.24B with net income of $210.00M and a profit margin of 0.17%. The stock has a beta of 1.21.
What sector is INDV in and who are its biggest institutional holders?
INDIVIOR PLC (INDV) operates in the Healthcare sector. It is held by 1 tracked hedge funds. See the ownership table above for the complete list.